Riskpilot← Back to searchSign inGet full accessBiopromic AB
ABActiveOrg 5590818844Anderstorpsvägen 16Research and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2025
SEK 240K
-90% vs 2024
EBITDA margin
58.8%
+184% vs 2024
Equity ratio
70.1%
Financial strength
Net profit 2025
SEK 107K
0 employees
| Revenue | SEK 240K | -90% |
| EBITDA | SEK 141K | +184% |
| Net profit | SEK 107K | — |
| Total assets | SEK 2,7M | -57% |
| Equity | SEK 1,9M | +6% |
| Employees | 0 | — |
Legal name
Biopromic AB
Org number
5590818844
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 oktober 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Hamasur, Beston
Company purpose
Företaget kommer att bedriva forskning och utveckling i fältmedicinsk utrustning, diagnostik och därmed förenlig verksamhet.
Address
Anderstorpsvägen 16
Email
beston.hamasur@biopromic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 9 366 | 8 369 | 7 804 | 5 654 | 4 807 | 1 726 | 2 341 | 240 |
| Staff expenses | — | — | — | — | — | — | — | — | −0 |
| EBITDA | −1 814 | 1 348 | 236 | 134 | 130 | 10 | −139 | −168 | 141 |
| Depreciation & amort. | −30 | −30 | −30 | −30 | −30 | −0 | −13 | −13 | −13 |
| EBIT | −1 844 | 1 318 | 206 | 104 | 100 | 10 | −152 | −181 | 128 |
| Net financials | — | — | — | — | — | — | 161 | 182 | 7 |
| Profit before tax | −1 844 | 1 318 | 206 | 104 | 100 | 10 | 9 | 0 | 135 |
| Tax | −0 | −0 | −0 | −0 | −0 | −1 | −0 | −0 | −28 |
| Net profit | −1 844 | 1 318 | 206 | 104 | 100 | 9 | 9 | 0 | 107 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 772 | 4 140 | 4 002 | 2 125 | 10 674 | 10 485 | 8 961 | 6 396 | 2 726 |
| Equity | 56 | 1 374 | 1 580 | 1 684 | 1 785 | 1 794 | 1 803 | 1 803 | 1 911 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 715 | 2 766 | 2 422 | 441 | 8 890 | 8 691 | 7 158 | 4 593 | 816 |
| Total debt | 1 715 | 2 766 | 2 422 | 441 | 8 890 | 8 691 | 7 158 | 4 593 | 816 |
EBITDA margin
58.8%
This company
15.8%
Market median
+272% vs market
20172025
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20172025
Return on equity
5.6%
This company
18.4%
Market median
-70% vs market
20172025
Net profit margin
44.7%
This company
8.1%
Market median
+452% vs market
20172025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20172025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20172025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-10-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
OR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 | — | — |
AK | Audit | 2020 | — | — |
SJ Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biopromic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Beston Hamasur | Chief Executive Officer | 0 companies |
| Omid Rasool | Deputy Chief Executive Officer | 0 companies |
| Anna Kristina Stenberg | Audit | 0 companies |
| Sebastian Johan Lennevi | Chief Auditor | 0 companies |
| Lech Karol Ignatowicz | Board of Directors | 0 companies |
| Malik Stephan Merza | Chairman | 0 companies |